Clinical Trial Update: Seroquel XR in Schizophrenia Relapse Prevention

View source ↗

Summary

A completed clinical trial evaluating Seroquel XR (quetiapine extended-release) for relapse prevention in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SEROQUEL XR (Quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia Relapse Prevention | Status: COMPLETED